Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Lopert

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Issue Brief (Commonwealth Fund)|July 31, 2009
Evidence-based decision-making within Australia's pharmaceutical benefits schemeRuth Lopert
Australian Health Review : a Publication of the Australian Hospital Association|July 1, 2009
PBS copayments and safety netsRuth Lopert
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 16, 2013
The high price of "free" trade: U.S. trade agreements and access to medicinesRuth Lopert, Deborah Gleeson
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 3, 2014
Revolution then evolution: the advance of health economic evaluation in AustraliaRuth Lopert, Rosalie Viney
JAMA|November 26, 2014
Costs of new treatments for hepatitis C infectionRuth Lopert, Craig Welch
Health Affairs (Project Hope)|November 6, 2007
Toward a rational, value-based drug benefit for MedicareRuth Lopert, Marilyn Moon
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and AustraliaRuth Lopert, Sara Rosenbaum
BMJ (Clinical Research Ed.)|July 28, 2010
Child influenza vaccination. Panvax febrile reactions not a predictorRuth Lopert, Terry Nolan
Health Affairs (Project Hope)|August 8, 2012
Willingness to pay for cancer therapyJonathan Silver, Ruth Lopert
Health Affairs (Project Hope)|April 10, 2013
Australia's 'fourth hurdle' drug review comparing costs and benefits holds lessons for the United StatesRuth Lopert, Adam G Elshaug
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Issue Brief (Commonwealth Fund)|July 31, 2009
Evidence-based decision-making within Australia's pharmaceutical benefits schemeRuth Lopert
Australian Health Review : a Publication of the Australian Hospital Association|July 1, 2009
PBS copayments and safety netsRuth Lopert
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 16, 2013
The high price of "free" trade: U.S. trade agreements and access to medicinesRuth Lopert, Deborah Gleeson
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|December 3, 2014
Revolution then evolution: the advance of health economic evaluation in AustraliaRuth Lopert, Rosalie Viney
JAMA|November 26, 2014
Costs of new treatments for hepatitis C infectionRuth Lopert, Craig Welch
Health Affairs (Project Hope)|November 6, 2007
Toward a rational, value-based drug benefit for MedicareRuth Lopert, Marilyn Moon
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 14, 2007
What is fair? Choice, fairness, and transparency in access to prescription medicines in the United States and AustraliaRuth Lopert, Sara Rosenbaum
BMJ (Clinical Research Ed.)|July 28, 2010
Child influenza vaccination. Panvax febrile reactions not a predictorRuth Lopert, Terry Nolan
Health Affairs (Project Hope)|August 8, 2012
Willingness to pay for cancer therapyJonathan Silver, Ruth Lopert
Health Affairs (Project Hope)|April 10, 2013
Australia's 'fourth hurdle' drug review comparing costs and benefits holds lessons for the United StatesRuth Lopert, Adam G Elshaug
Pageof 5